BioLineRx (BLRX) Net Income (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -83.68% |
| Sep 30, 2025 | 0.72% |
| Jun 30, 2025 | 8.35% |
| Mar 31, 2025 | -528.90% |
| Dec 31, 2024 | 111.75% |
| Sep 30, 2024 | -5.55% |
| Jun 30, 2024 | 5.26% |
| Mar 31, 2024 | 75.25% |
| Dec 31, 2023 | -19.99% |
| Sep 30, 2023 | -37.72% |
| Jun 30, 2023 | 9.06% |
| Mar 31, 2023 | -34.90% |
| Dec 31, 2022 | 1.01% |
| Sep 30, 2022 | 6.17% |
| Jun 30, 2022 | -22.61% |
| Mar 31, 2022 | 5.02% |
| Dec 31, 2021 | -3.90% |
| Sep 30, 2021 | 3.86% |
| Jun 30, 2021 | -22.01% |
| Mar 31, 2021 | 5.63% |
| Dec 31, 2020 | -23.79% |
| Sep 30, 2020 | 16.11% |
| Jun 30, 2020 | 18.31% |
| Mar 31, 2020 | 25.79% |
| Dec 31, 2019 | -46.08% |
| Sep 30, 2019 | 1.14% |
| Jun 30, 2019 | -19.20% |
| Mar 31, 2019 | 24.58% |
| Dec 31, 2018 | -7.90% |
| Sep 30, 2018 | -11.38% |
| Jun 30, 2018 | 13.11% |
| Mar 31, 2018 | 15.87% |
| Dec 31, 2017 | -7.67% |
| Sep 30, 2017 | -41.15% |
| Jun 30, 2017 | -1.01% |
| Mar 31, 2017 | -12.59% |
| Dec 31, 2016 | 0.35% |
| Sep 30, 2016 | -14.29% |
| Jun 30, 2016 | -3.97% |
| Mar 31, 2016 | 9.52% |
| Dec 31, 2015 | -17.04% |
| Sep 30, 2015 | 13.44% |
| Jun 30, 2015 | 6.56% |
| Mar 31, 2015 | -11.94% |
| Dec 31, 2014 | -113.00% |
| Sep 30, 2014 | 48.36% |
| Jun 30, 2014 | 5.47% |
| Mar 31, 2014 | -83.65% |
| Dec 31, 2013 | 23.18% |
| Sep 30, 2013 | 31.98% |
| Jun 30, 2013 | 34.24% |